BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21176724)

  • 21. An overview of erdosteine antioxidant activity in experimental research.
    Moretti M; Marchioni CF
    Pharmacol Res; 2007 Apr; 55(4):249-54. PubMed ID: 17267240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
    Demiralay R; Gürsan N; Erdem H
    Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine.
    Erdogan H; Fadillioglu E; Yagmurca M; Uçar M; Irmak MK
    Urol Res; 2006 Feb; 34(1):41-6. PubMed ID: 16429300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokers.
    Basyigit I; Yildiz F; Cekmen M; Duman C; Bulut O
    Drugs R D; 2005; 6(2):83-9. PubMed ID: 15777101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue.
    Terzi A; Iraz M; Sahin S; Ilhan A; Idiz N; Fadillioglu E
    Toxicol Ind Health; 2004 Sep; 20(6-10):141-7. PubMed ID: 15941011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats.
    Kuvandik G; Duru M; Nacar A; Yonden Z; Helvaci R; Koc A; Kozlu T; Kaya H; Sogüt S
    Toxicol Pathol; 2008 Jul; 36(5):714-9. PubMed ID: 18648099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-Protective Effect of Erdosteine on Multiple-Organ Injuries Induced by Fine Particulate Matter.
    Cao L; Ping F; Zhang F; Gao H; Li P; Ning X; Cui G; Ma Z; Jiang X; Li S; Han S
    Med Sci Monit; 2021 Dec; 27():e930909. PubMed ID: 34873140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
    Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
    Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measurement of bronchoconstrictive eicosanoids in chronic obstructive pulmonary disease].
    Gross-Sondej I; Soja J; Sładek K; Pulka G; Skucha W; Niżankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2012; 80(2):120-6. PubMed ID: 22370980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
    Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
    Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies.
    Cabuk M; Gurel A; Sen F; Demircan N
    Mol Cell Biochem; 2008 Jan; 308(1-2):35-42. PubMed ID: 17899318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
    Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
    Moretti M; Fagnani S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary disease.
    Drozdovszky O; Barta I; Antus B
    Respiration; 2014; 87(5):408-15. PubMed ID: 24714447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children.
    Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells.
    Demiralay R; Gürsan N; Erdem H
    J Appl Toxicol; 2007; 27(3):247-54. PubMed ID: 17216608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
    Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
    Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
    Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
    Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory Effect of Erdosteine in Lipopolysaccharide-Stimulated RAW 264.7 Cells.
    Park JS; Park MY; Cho YJ; Lee JH; Yoo CG; Lee CT; Lee SM
    Inflammation; 2016 Aug; 39(4):1573-81. PubMed ID: 27317418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The protective effect of erdosteine on radiocontrast induced nephrotoxicity in rats.
    Yesilyurt A; Aydın Erden I; Bilgiç I; Erden G; Albayrak A
    Environ Toxicol; 2011 Aug; 26(4):395-402. PubMed ID: 21384492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.